Plenary: Prime Time, Friday
Plenary: Prime Time
University of California, Davis
Dr. Evans is professor and chairman of the Department of Urology at University of California, Davis School of Medicine and a member of the UC Davis Cancer Center. Dr. Evans attended Dartmouth Medical School on a Health Professional Services Program scholarship and he served on active duty in the United States Army, including two years as Chief of Experimental Surgery at the Walter Reed Army Institute of Research. He completed surgery and urology training at the University of California, San Francisco where he was also a National Kidney Foundation Scholar. He completed fellowship training in urologic oncology at the University of Texas, M.D. Anderson Cancer Center. He came to UC Davis in 1997 and was also Director of Urology Research. In 2006, he became Department Chairman. In 2010 he became Chairman of the UC Davis Medical Group Practice Management Board. Dr. Evans’ practice is dedicated to the management of patients with urologic malignancies. He works with medical oncologists and radiation oncologists to provide multimodal approaches to cancer therapy.
Dr. Evans’ research laboratory focuses on prostate cancer; specifically, mechanisms signaling the androgen receptor to activate prostate cancer growth and progression following castration. His laboratory has developed models to study this and has identified novel mechanisms that activate the androgen receptor. His laboratory work has tested new agents and brought them from bench studies to animal models to clinical trials.
Dr. Evans is president-elect of the Society of Urologic Oncology and is Immediate Past Chair of the ASCO-GU Steering Committee. He is also an elected member of the American Association of Genitourinary Surgeons. His research laboratory has received funding from the National Institutes of Health, Department Of Defense, New York Academy of Medicine, Prostate Cancer Foundation, Stand-Up To Cancer and the American Cancer Society. He has published over 150 peer-reviewed articles.
University of California San Diego
Christopher J. Kane, MD, FACS, Professor and Chair, Department of Urology, UC San Diego Health System, Joseph D. Schmidt MD Presidential Chair in Urology;
Dr. Kane is on the Executive Governing Board of UC San Diego Health Sciences and the Executive leadership team of the UC San Diego Moores Comprehensive Cancer Center. Kane is also on the Board of Directors of UCSD’s Clinically Integrated Network.
Dr. Kane completed his urology residency at Oakland Naval Hospital and UC San Francisco. He earned his medical degree at Uniformed Services University and his bachelors of science degree in mechanical engineering at UC Davis. Dr. Kane was recruited from UCSF to lead the Division of Urology at UCSD in 2007. Since at UCSD, the Urology program has expanded significantly in every domain including clinical, educational and research and is now highly ranked nationally. Urology became a clinical department in 2013 and will become a new academic department at UCSD in 2017.
He was Co-Chair of the Renal Cell Carcinoma Advisory Task Force, National Cancer Institute from 2012-2016. He is on the NCCN treatment guidelines in prostate cancer committee. He was elected to American Association of GU Surgeons in 2014. He was selected as a “Top Doctor” in San Diego in 2008-2016 and was selected as one of two Physician Healthcare Champions for 2010 in San Diego by the San Diego Business Journal. He was awarded the Distinguished Engineering Alumni Medal by UC Davis in 2011. He is a retired Navy Captain and a decorated veteran of Desert Storm. Dr. Kane has authored more than 275 publications and book chapters, primarily on prostate cancer risk factors and outcomes, prostate cancer surgery, and minimally invasive surgery for prostate and kidney cancer.
Washington University in Saint Louis
Gerald L. Andriole, Jr., MD, is the Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Barnes-Jewish Hospital, the Siteman Cancer Center and Washington University School of Medicine in St. Louis, Missouri.
Dr. Andriole received his medical degree from Jefferson Medical College in Philadelphia, Pennsylvania. He trained in surgery at Strong Memorial Hospital and the University of Rochester and completed urology residency at Brigham and Women’s Hospital and Harvard Medical School. Subsequently, he was a fellow in Urologic Oncology at the National Cancer Institute in Bethesda, Maryland.
Dr. Andriole has over 30 years of consistent contributions in the areas of BPH and prostate cancer screening and prevention research. He has contributed well over 350 peer-reviewed publications and serves on the editorial boards of several prestigious journals. He is Chairman of the Prostate Committee of the National Cancer Institute’s Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and PI of the NIDDK Multidisciplinary Approach to Urologic Pelvic Pain (MAPP) and Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). He was Chairman of the Steering Committee of the REDUCE Prostate Cancer Prevention Trial as well as PI of the NIDDK Medical Therapy of Prostatic Symptoms (MTOPS) BPH trial, and of the NIDDK Complementary and Alternative Medicine for Urinary Symptoms (CAMUS) study. He is a member of the American Urological Association, American Association for Cancer Research, the American Society of Clinical Oncology, American Surgical Association, the American Association of Genitourinary Surgeons and the Clinical Society of Genitourinary Surgeons, among other societies.
Sunday, May 14
4:00 PM – 6:00 PM
Samaritan Medical Center, Watertown, New York
Dr. Alejandro Remigio Rodríguez is the Chief of Urology and Urology Oncology – Director of Robotics and Minimally Invasive Surgery at Samaritan Medical Center in Watertown, New York. He is American Board of Urology Certified, and the present Treasurer of the Confederación Americana de Urología (CAU).
He worked as an Assistant Professor of Urology, Director for Robotics and Laparoscopic Surgery at the University of South Florida Morsani College of Medicine, in Tampa, Florida from 2011-2012. He is Fellowship trained in Urology Oncology at Moffitt Cancer Center in Tampa, and Fellowship trained in Urology Oncology and Minimally Invasive Surgery in Rennes - France. He completed Urology training and Chief Residency in the Department of Urology of the University of South Florida Morsani College of Medicine, in Tampa, Florida.
He is an active member of multiple societies such as the AUA, SIU, CAU, EAU, SUO, Endourological Society, Society of Robotic Surgeons, SLS, GURS, and Sociedad Peruana de Urología.
Prior to his career in the USA and France, he worked as a Urologist in Lima-Peru, after having completed a Urology Residency at the Universidad Nacional Mayor de San Marcos, back in 1998. He obtained his medical doctor degree in 1993 from the Autonomous University of Guadalajara in Mexico, having graduated at top of his class.
Dr. Rodríguez has published over 200 peer review manuscripts and abstracts. He has participated as invited speaker in multiple national and international meetings. His passion is innovation in minimally invasive surgical approaches (Robotics and Laparoscopy) for malignant and benign diseases in urology. Among some honors and awards that he has received, are the following: Murphy Scholar Award in Prostate diseases in 2006, 2008, and 2009; SLS Outstanding Laparoendoscopic surgeon award in 2009, 2010 and 2011; America’s Top Surgeon – Urology in 2014, 2015, 2016.
Friday, May 12
3:30 PM – 3:50 PM
Monday, May 15
7:00 AM – 9:00 AM